From policy to practice: overcoming barriers to harm reduction vending machine deployment

Drug overdose deaths remain a leading cause of mortality in the U.S., largely driven by a drug supply frequently contaminated with fentanyl. Harm reduction vending machines (HRVMs) provide low-barrier access to naloxone and fentanyl testing strips (FTS). However, legacy state laws may prevent their use. This brief report describes how a large academic medical center in Georgia identified a legal barrier, advocated for legislative change (SB 395/Wesley’s Law), and launched a community distribution model. A legal review identified an outdated law (O.C.G.A. § 26-4-89) that prohibited dispensing of any drugs via vending machine, classifying it as a misdemeanor. The medical center partnered with state public health officials to advocate for SB 395, which passed and legalized stocking vending machines with opioid antagonists while expanding access in schools and government buildings. Since their implementation in December 2024, two machines have distributed more than 3,550 two-dose naloxone kits and 4,200 FTS. Key challenges include securing sustainable funding beyond one-time donations and strategically placing machines to protect user privacy while maintaining easy access. Georgia’s experience demonstrates the importance of identifying and dismantling regulatory hurdles that stall harm reduction efforts. SB 395 provides a template for other states to modernize legacy laws. While HRVMs effectively expand access to life-saving tools, long-term scaling requires recurring funding and machine placement that carefully balances visibility with engagement and privacy.